<DOC>
	<DOC>NCT02967484</DOC>
	<brief_summary>This study evaluate the effects of acupuncture method on the recurrence of ischemic stroke patients.Half of participants will receive "Huo Xue San Feng" acupuncture combining 1 antihypertensive medication on the routine ischemic stroke treatments' basis. While the other half will receive 1 antihypertensive medication and basic treatments for ischemic stroke.</brief_summary>
	<brief_title>Acupuncture Lowering Blood Pressure for Secondary Prevention of Stroke</brief_title>
	<detailed_description>Under recuiting 480 patients come from 5 hospitals in China.Eligible patients will be randomly assigned into 2 groups: treatment group and control group. The treatment group will receive "Huo Xue San Feng" acupuncture combining 1 antihypertensive medication on the routine ischemic stroke treatments' basis. The control group will receive 1 antihypertensive medication and basic treatments for ischemic stroke. "Huo Xue San Feng" acupuncture will be given six sessions weekly for the first 6 weeks and three times weekly for the next 6 weeks. A 9-month follow-up will thereafter be conducted. Antihypertensive medications will be adjusted based on BP levels.</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Patients with the first time ischemic stroke Patients meet the TCM diagnosis standard of Stroke Patients meet the diagnosis standard of hypertension, taking only 1 type of antihypertensive drugs for at least 2 weeks before admission,corresponding to systolic pressure ranging from 140 to 160mmHg and Diastolic ranging from 90100mmHg. The course of Ischemic stroke ranging from 2 weeks to 6 weeks . Men or Women Aged between 35 and 70 years old. Patients who are willing to participate in our clinical trial agree to sign the informed consent form. Patients who have been diagnosed with secondary hypertension. Patients have taken beta blockers or diuretics or non dihydropyridine calcium channel blocker （NDHPCCB）for a long time because of cardiovascular disease. Patients who taking 1 type of antihypertensive drugs,blood pressure under 140/90mmHg. Patients accompanied with other neurological disorders,such as epilepsy, peripheral nerve injury, Patients accompanied with severe medical condition such as severe hematopoietic system disease, coagulation dysfunction and malignant tumor. Patients accompanied with diabetic nephropathy,severe liver and renal insufficiency,severe cardiac or pulmonary dysfunction,severe arrhythmia. Patients who have occured skin infections near the acupoint location. Pregnant or breastfeeding women. Patients who currently participate in another clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acupuncture</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Second prevention of Stroke</keyword>
	<keyword>Efficacy</keyword>
	<keyword>RCT</keyword>
	<keyword>Study protocol</keyword>
</DOC>